Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 25 - Drugs for disorders of the nervous system
Patents for A61P 25 - Drugs for disorders of the nervous system (183,225)
12/1999
12/16/1999WO1999064401A2 Imidazolyl derivatives and their use as somatostatin receptor ligands
12/16/1999WO1999064400A1 INHIBITORS OF p38
12/16/1999WO1999064389A1 Inhibitors of the anandamide transporter as analgesic agents
12/16/1999WO1999064388A1 Hyperforin derivatives, the use thereof and formulations containing them
12/16/1999WO1999064059A2 Use of secretin for the treatment of autism and other neurological, behavioral and immunological disorders
12/16/1999WO1999064055A1 Multivalent agonists, partial agonists, inverse agonists and antagonists of the 5ht4 receptors
12/16/1999WO1999064053A1 β3-ADRENERGIC RECEPTOR AGONISTS
12/16/1999WO1999064052A1 Novel leukotriene receptor antagonists and their uses
12/16/1999WO1999064042A1 Novel therapeutic agents that modulate alpha-1a adrenergic receptors
12/16/1999WO1999064041A1 Multibinding agents that modulate nmda receptors
12/16/1999WO1999064039A1 Bradykinin antagonists
12/16/1999WO1999064038A1 Novel analgesic agents
12/16/1999WO1999064035A1 β2-ADRENERGIC RECEPTOR AGONISTS
12/16/1999WO1999064034A1 β2-ADRENERGIC RECEPTOR AGONISTS
12/16/1999WO1999064031A1 β2-ADRENERGIC RECEPTOR AGONISTS
12/16/1999WO1999064028A1 Protecting neurons from ischemia
12/16/1999WO1999064027A1 Extracts of hypericum perforatum and formulations containing them
12/16/1999WO1999064021A1 hCEPR RECEPTOR
12/16/1999WO1999064011A1 Drugs
12/16/1999WO1999064010A1 Use of a nk-1 receptor antagonist for treating psychiatric disorders
12/16/1999WO1999064007A1 Use of a nk-1 receptor antagonist for treating bipolar disorders
12/16/1999WO1999064006A1 Use of a nk-1 receptor antagonist for treating psychiatric disorders
12/16/1999WO1999064000A1 Novel therapeutic agents that modulate neurokinin receptors
12/16/1999WO1999063999A1 H1-histamine receptor antagonists
12/16/1999WO1999063998A1 Novel use of hiv protease inhibiting compounds
12/16/1999WO1999063996A1 Multivalent agonists, partial agonists, inverse agonists and antagonists of the 5ht2 receptors
12/16/1999WO1999063993A1 Multivalent agonists, partial agonists, inverse agonists and antagonists of the d1 receptors
12/16/1999WO1999063983A1 MULTIBINDING AGENTS THAT MODULATE PPARη AND RXR RECEPTORS
12/16/1999WO1999063973A2 PHARMACEUTICAL COMPOSITIONS AND USES FOR ANDROST-5-ENE-3β,17β-DIOL
12/16/1999WO1999063944A2 Novel therapeutic agents that modulate estrogen receptors
12/16/1999WO1999063936A2 Novel therapeutic agents that modulate endothelin receptors
12/16/1999WO1999063933A2 Multivalent agonists, partial agonists and antagonists of the gaba receptors
12/16/1999WO1999063930A2 Novel angiotensin receptor modulators and their uses
12/16/1999WO1999055686A3 Process for the preparation of tetralone imines for the preparation of active pharmaceutical compounds
12/16/1999WO1999054280B1 Cubane derivatives as metabotropic glutamate receptor antagonists and process for their preparation
12/16/1999WO1999050268A3 Substituted indolealkanoic acids
12/16/1999WO1999043807A3 Human channel-related molecules
12/16/1999WO1999006540A3 Inhibitors of cell-cycle progression and uses related thereto
12/16/1999CA2337822A1 Inhibitors of the anandamide transporter as analgesic agents
12/16/1999CA2335339A1 .beta.-carboline compounds
12/16/1999CA2334990A1 Novel use of hiv protease inhibiting compounds
12/16/1999CA2334979A1 Benzamides with tetrahydrofuranyloxy substitutents as phosphodiesterase 4 inhibitors
12/16/1999CA2334945A1 Imidazolyl derivatives
12/16/1999CA2334814A1 Tetrahydroisoquinoline derivatives as modulators of dopamine d3 receptors
12/16/1999CA2334798A1 1,5-benzodiazepine derivatives
12/16/1999CA2334671A1 Pyrido¬2,3-b|indolizine derivatives and aza analogues thereof; crf1 specific ligands
12/16/1999CA2334625A1 Extracts of hypericum perforatum and formulations containing them
12/16/1999CA2334611A1 Use of a nk-1 receptor antagonist for treating psychiatric disorders
12/16/1999CA2334609A1 Use of a nk-1 receptor antagonist for treating psychiatric disorders
12/16/1999CA2334580A1 Use of a nk-1 receptor antagonist for treating bipolar disorders
12/16/1999CA2333691A1 Heterobicyclic and tricyclic nitric oxide synthase inhibitors
12/16/1999CA2333657A1 Use of secretin for the treatment of autism and other neurological, behavioral and immunological disorders
12/16/1999CA2333629A1 Furopyridine derivatives and their therapeutical use
12/16/1999CA2331918A1 Protecting neurons from ischemia
12/16/1999CA2331794A1 Acetylcholine enhancers
12/16/1999CA2329685A1 Proteins regulating gene expression
12/16/1999CA2321273A1 Novel analgesic agents
12/16/1999CA2321170A1 Multivalent agonists, partial agonists, inverse agonists and antagonists of the d1 receptors
12/16/1999CA2321152A1 Novel therapeutic agents that modulate endothelin receptors
12/16/1999CA2321120A1 .beta.3-adrenergic receptor agonists
12/16/1999CA2320926A1 Novel leukotriene receptor antagonists and their uses
12/16/1999CA2319756A1 Novel therapeutic agents that modulate alpha-1a adrenergic receptors
12/16/1999CA2319751A1 Multivalent agonists, partial agonists, inverse agonists and antagonists of the 5ht2 receptors
12/16/1999CA2319730A1 Bradykinin antagonists
12/16/1999CA2319651A1 H1-histamine receptor antagonists
12/16/1999CA2319643A1 Multivalent agonists, partial agonists, inverse agonists and antagonists of the 5ht4 receptors
12/16/1999CA2319497A1 Novel therapeutic agents that modulate estrogen receptors
12/16/1999CA2319496A1 Multivalent agonists, partial agonists and antagonists of the gaba receptors
12/16/1999CA2319175A1 Multibinding agents that modulate nmda receptors
12/16/1999CA2319159A1 Novel therapeutic agents that modulate neurokinin receptors
12/16/1999CA2319068A1 Novel angiotensin receptor modulators and their uses
12/16/1999CA2318894A1 .beta.2-adrenergic receptor agonists
12/16/1999CA2318286A1 Multibinding agents that modulate ppar.gamma. and rxr receptors
12/16/1999CA2318055A1 .beta.2-adrenergic receptor agonists
12/15/1999EP0963987A2 Spiro(piperidine-4,1'-pyrrolo(3,4-c)pyrrole)
12/15/1999EP0963985A2 Di-or triaza-spiro(4,5)decane derivatives
12/15/1999EP0963984A1 Heteroarylpiperidines and piperazines and their use as antipsychotics and analgetics
12/15/1999EP0963983A1 Indol-2-ones as serotonin modulators
12/15/1999EP0963431A1 NOVEL FabH
12/15/1999EP0963372A1 5-aminoalkoxy-1,4-dihydroquinoxaline-2,3-diones being dopamine agonists
12/15/1999EP0788366B1 Use of 2'-substituted oligonucleotides to down-regulating gene expression
12/15/1999EP0642504B1 (3s,4s)-delta-6-tetrahydrocannabinol-7-oic acids and derivatives thereof, processes for their preparation and pharmaceutical compositions containing them
12/15/1999CN1238782A Colostrinin and uses thereof
12/15/1999CN1238781A Heptapeptide oxytocin analofues
12/15/1999CN1238779A Method and compounds for inhibiting 'beta'-amyloid peptide release and/or synthesis
12/15/1999CN1238771A 2-imidazolinylaminoindole compounds useful as alpha-2 adrenoceptor agonists
12/15/1999CN1238766A 3-alkoxyisoxazol-4-yl-substituted 2-amino carboxylic acid compounds
12/15/1999CN1238761A Benzamidoaldehydes and their use as cryteine protease inhibitors
12/15/1999CN1238760A N-(aryl/heteroaryl/alkyl acetyl) amino acid esters, pharmaceutical composition comprising same, and methods for inhibiting beta-amyloid peptide release and/or its synthesis by use of such compounds
12/15/1999CN1238692A Medicines for treating detentia or congitive disorder which comprises asiatic acid derivatives
12/15/1999CN1238181A Nefazodone dosage form
12/15/1999CN1047386C Novel spiro [indole-pyrrolidine] derivatives as melatoninergic agonists, method for preparing same and use thereof as drug
12/15/1999CN1047385C 3-indolylpiperidine and medinal composition containing them
12/14/1999US6002014 Selectively inhibiting the action of cox-2; treating inflammation
12/14/1999US6002009 Di-substituted 1,4-piperidine esters and amides having 5-HT4 antagonistic activity
12/14/1999US6001987 Isolated nucleotide sequences associated with Multiple sclerosis
12/14/1999US6001972 Splicing variant of the epstein-barr virus-induced G-protein coupled receptor
12/14/1999US6001970 Modified human neuropeptide Y1 Receptors
12/14/1999US6001876 Administering analogs of 4-aminobutyric acid to treat pain in mammals
12/14/1999US6001852 Clioquinol for the treatment of Alzheimer's disease
1 ... 1528 1529 1530 1531 1532 1533 1534 1535 1536 1537 1538 1539 1540 1541 1542 1543 1544 1545 1546 1547 1548 ... 1833